Fundz

Moonwalk Biosciences Appoints John Liles as VP Biology and Translational Science

PRIVATEAug 19, 2024

Position

Vice President

Company

Moonwalk Biosciences

John Liles
john.liles@moonwalk.bio
San FranciscoBiotechnology

Description

Moonwalk Biosciences announced the appointment of John Liles, Ph.D., as VP Biology and Translational Science, and the formation of a world class Cardiometabolic Advisory Board. Dr. Liles brings deep experience as a drug discovery biologist with proven success advancing novel therapeutics from target discovery through IND for liver, kidney, lung and cardiovascular diseases.

Who to call at Moonwalk Biosciences, and when

A new leader at Moonwalk Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Moonwalk Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Moonwalk Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Moonwalk Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Moonwalk Biosciences

Location

2 TOWER PLACE, 17TH FLOOR

San Francisco, California, United States

About

Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering. The combination enables both a novel discovery platform and a path to developing therapeutics that include both epigenetic engineering and other traditional modalities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Moonwalk Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Rigel
Senior decision-maker at this company
••••••••@••••••••

See Rigel's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Moonwalk Biosciences's next move

Learn about Strategic plan

Moonwalk Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.